Narendra Modi launches vaccination drive against COVID-19, says campaign will ensure 'decisive victory' over pandemic

-

New Delhi: Prime Minister Narendra Modi on Saturday launched India's COVID-19 vaccination drive and asserted that the made-in-India vaccines being rolled out will ensure a "decisive victory" for the country over the coronavirus pandemic.

Addressing the nation ahead of the launch, Modi reminded people that two doses of vaccine are very important and asked them to maintain wearing masks and social distancing even after receiving the jabs.

During his speech, Modi turned emotional as he spoke of the disruption the pandemic caused to people's lives, isolating victims of the coronavirus and denying the dead traditional last rites.

In a choked voice, the prime minister also referred to sacrifices made by healthcare and frontline workers, hundreds of whom lost their lives to the viral infection.

He also urged the country to show patience during the vaccination drive as it had shown till now in fighting the pandemic.

Normally, it takes years to make a vaccine but in such a short span of time, not one, but two 'Made in India' vaccines are ready, Modi said, adding work on other vaccines is also progressing at a fast pace.

India getting two vaccines in such a short time is a testimony to the talent and skills of the nation's scientists, the prime minister said.

"Our vaccination programme is driven by humanitarian concerns, those exposed to maximum risk will get priority," he said.

Modi said that scientists and experts have given permission for emergency use of the made-in-India vaccines only after being absolutely sure of their safety and the people should be aware of any propaganda and rumours.

The made-in-India vaccines will ensure a "decisive victory" for the country over the coronavirus pandemic, he asserted.

The Drugs Controller General of India (DCGI) had earlier this month approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.

This will be the world's largest vaccination programme covering the entire length and breadth of the country.

According to the government, the shots will be offered first to an estimated one crore healthcare workers, and around two crore frontline workers, and then to persons above 50 years of age, followed by persons younger than 50 years of age with associated comorbidities.

Cost of vaccination of healthcare and frontline workers will be borne by the central government.



from Firstpost India Latest News https://ift.tt/39Eh74e
Press Trust of India

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

120 flights delayed, 30 trains running late; Delhi fog & cold wave continue to give shiver to travellers

-
Arrival and departure of 120 flights, both domestic and international, to Delhi airport were affected due to dense fog and cold wave conditions on Wednesday, according to Delhi Airport FIDS (Flight Information Display System). As per the Delhi Airport FIDS, a total of 53 flights, including 21 domestic arrivals, 16 domestic departures, 13 international departures and three international arrivals scheduled are cancelled and not operating due to fog and other operational reasons from and to Indira Gandhi International (IGI) Airport in the national capital on 17 January. #WATCH | Delhi: Several flight operations delayed at IGI airport due to low visibility amid fog. pic.twitter.com/hG1DUKllEt — ANI (@ANI) January 17, 2024 Visuals from the Delhi airport showed passengers waiting outside, checking update of their scheduled flights. There were also some people waiting for flight of their families, friends and loved ones to arrive, which got delayed due to fog. #WATCH | Delhi | Pas
Read more